TABLE 9.

Fluconazole and voriconazole agar disk gradient MICs for C. albicans^a

Country (no. of sites in 2001)	Fluconazole			Voriconazole
	MIC50	MIC90	n	MIC50	MIC90	n
Argentina (2)	0.32	1.84	607	0.019	0.128	471
Australia (1)	0.53	64.98	21	0.019	0.789	21
Belgium (2)	<0.25	0.68	450	<0.008	0.040	372
Brazil (1)	<0.25	1.44	446	<0.008	0.061	333
Canada (2)	0.41	1.12	87	0.019	0.085	87
China (2)	0.87	3.90	93	0.053	0.196	92
Colombia (2)	1.44	10.58	390	0.082	1.118	369
Czech Republic (2)	0.68	3.90	938	0.046	0.350	720
Ecuador (1)	2.37	42.11	250	0.096	>4.80	174
France (4)	0.87	3.90	456	0.046	0.262	274
Germany (5)	<0.25	1.12	299	0.014	0.061	299
Greece (1)	<0.25	1.28	88	<0.008	0.061	88
Hungary (5)	0.87	10.58	1,016	0.061	1.496	873
Italy (7)	0.68	5.00	696	0.030	0.262	696
Malaysia (1)	0.41	3.04	1,246	0.046	0.350	521
Mexico (2)	1.12	4.45	23	0.082	1.512	18
The Netherlands (1)	0.32	1.12	1,204	0.014	0.061	1,204
Poland (1)	0.41	1.12	170	0.046	0.146	45
Russia (1)	3.04	91.22	11	0.061	0.262	4
Slovakia (4)	0.87	5.00	391	0.046	0.977	391
South Africa (5)	0.41	2.37	1,049	0.019	0.109	1,010
South Korea (1)	0.53	1.84	426	0.026	0.146	347
Spain (2)	0.41	3.04	969	0.014	0.146	966
Switzerland (2)	0.41	1.84	161	0.019	0.082	161
Taiwan (3)	1.44	6.42	399	0.082	0.625	394
Thailand (2)	0.68	2.70	130	0.034	0.262	129
Turkey (2)	0.68	3.47	141	0.046	0.350	111
United Kingdom (3)	0.53	3.04	977	0.019	0.146	692
United States (9)	0.53	3.04	676	0.026	0.196	682
Venezuela (1)	1.44	5.00	120	0.071	0.350	98

^aAll specimen types were tested, all locations were in hospitals and only 2001 data are shown. Test range: fluconazole, <0.25 to >165 μg/ml; voriconazole, <0.008 to >4.8 μg/ml.